https://cannabisdna.com/wp-content/uploads/2019/08/snooze-with-pot-header.jpg

According to the National Sleep Foundation, 50 to 70 million U.S. adults experience symptoms of a sleep disorder. About 30 to 40 percent of the population will experience insomnia at some point in their lives, and about 10 to 15 percent of adults will deal with chronic insomnia. With so many people experiencing sleeping disorders, there’s been a rise of...

https://cannabisdna.com/wp-content/uploads/2019/07/woman-sick-at-sink.jpg

Nausea is the feeling of unease and discomfort with an urge to vomit. It is a common effect associated with chemotherapy, migraines, motion sickness, inflammatory gastrointestinal conditions, general anesthesia, food poisoning, stomach flu, and many other conditions. While cannabis may have the potential to treat several sources of nausea, the most well-studied is chemotherapy-induced nausea...

https://cannabisdna.com/wp-content/uploads/2019/07/buds-in-a-row.jpg

‘With a Little Help from My Friends’ CBN One person’s oxidation product is another’s therapeutic relief. While generally found only in trace amounts in cannabis, tetrahydrocannabinol (THC) converts to cannabinol (CBN) when exposed to air, heat (160°C/320°F – 180°C/356°F) and/or light over time through an oxidation process1,2. While trying to determine the main psychoactive component...

https://cannabisdna.com/wp-content/uploads/2019/06/sunset-with-plant.jpg

CBD, Cure-All Elixir or Snake Oil? Almost everywhere you look now, you see products infused with cannabidiol (CBD) including skincare, beverages, tinctures, oils, food, and the list goes on! The once overlooked compound, CBD, is now reaching the mainstream. CBD was discovered by Dr. Roger Adams who isolated CBD for the first time in 19421....

CannabisDNA Logo
Follow Us
Subscribe to Us

Copyright © 2019 Pathway | All Rights Reserved
Product not available to New York residents.
This test is not for diagnostic use. Read Full Disclaimer.
Notice of Privacy Practices & HIPAA Compliance.
Patent Pending USPTO #20170253928 & USPTO #62/767,237